Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 11 EP applications Caroline Romanowski has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11761652

BIOTINYLATED POLYSACCHARIDES HAVING AN ANTITHROMBOTIC ACTIVITY AND IMPROVED METABOLIC STABILITY

IPC classification:
A61K 31/727, C08B 37/08
Agent:
Caroline Romanowski, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12718395

POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS

IPC classification:
A61K 31/727, C08B 37/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
EXAMINATION REQUESTED
EP12719984

SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY

IPC classification:
A61K 31/00, A61K 31/727, A61P 7/02, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11738298

AN ANTITUMORAL COMBINATION COMPRISING OMBRABULIN, A TAXANE DERIVATIVE AND A PLATINUM DERIVATIVE

IPC classification:
A61K 31/167, A61K 31/282, A61K 31/337, A61K 31/555, A61K 33/24, A61K 45/06, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11730928

SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11727182

SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPAEDIC SURGERY

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11729952

SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY

IPC classification:
A61K 31/727, A61P 7/02
Applicant:
Aventis Pharma S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305130

Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients

IPC classification:
A61K 31/277, A61K 31/505, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION REFUSED
EP12702546

IDRABIOTAPARINUX FOR THE TREATMENT OF PULMONARY EMBOLISM AND FOR THE SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS

IPC classification:
A61K 31/7056, A61K 31/715, A61P 7/02
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14761286

PYRAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF BLADDER CANCER

IPC classification:
A61K 31/437, A61K 31/444, A61K 31/4545, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Cabinet Nony
Agent:
Caroline Romanowski, Sanofi
Status:
GRANT OF PATENT INTENDED
EP11746655

DERIVATIVES OF OXADIAZOLE AND PYRIDAZINE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

IPC classification:
A61K 31/425, A61P 3/00, C07D 237/20, C07D 271/06
Applicant:
Sanofi, S.A.
Agent:
Caroline Romanowski, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature